Sarepta stock extends decline as company declines FDA call to withdraw drug

5 hours ago 3
ARTICLE AD BOX
Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta stock extends decline as company declines FDA call to withdraw drug

Related

Figma’s IPO seeks a $13 billion valuation, with a bitcoin investment as a sweetener

Figma’s IPO seeks a $13 billion valuation, with a bitcoin in...

17 minutes ago 0
15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love them

15 stocks of companies set to grow sales twice as fast as th...

40 minutes ago 0
Why investors may be in for a long summer with no easy resolution on tariffs

Why investors may be in for a long summer with no easy resol...

41 minutes ago 0

Trending

1. carlos taberner
2. gunther wwe
3. $open
4. weather kansas city
5. schd
6. steelers throwback uniforms
7. joby stock
8. f stock
9. hunter biden
10. rebecca sramkova

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

5 months ago 231
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

5 months ago 192
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

5 months ago 191
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

5 months ago 178
Metal Gear Solid Delta: Snake Eater release date leaks on the PlayStation Store

Metal Gear Solid Delta: Snake Eater release date leaks on th...

5 months ago 170
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved